Genor Biopharma Holdings (HKSE:06998) Days Sales Outstanding : 0.00 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Genor Biopharma Holdings Days Sales Outstanding?

Genor Biopharma Holdings's average Accounts Receivable for the six months ended in Jun. 2024 was HK$0.00 Mil. Genor Biopharma Holdings's Revenue for the six months ended in Jun. 2024 was HK$15.58 Mil. Hence, Genor Biopharma Holdings's Days Sales Outstanding for the six months ended in Jun. 2024 was 0.00.

The historical rank and industry rank for Genor Biopharma Holdings's Days Sales Outstanding or its related term are showing as below:

During the past 6 years, Genor Biopharma Holdings's highest Days Sales Outstanding was 30.82. The lowest was 16.60. And the median was 23.71.

HKSE:06998's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 70.71
* Ranked among companies with meaningful Days Sales Outstanding only.

Genor Biopharma Holdings's Days Sales Outstanding stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Genor Biopharma Holdings Days Sales Outstanding Historical Data

The historical data trend for Genor Biopharma Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genor Biopharma Holdings Days Sales Outstanding Chart

Genor Biopharma Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

16.60

Genor Biopharma Holdings Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Genor Biopharma Holdings's Days Sales Outstanding

For the Biotechnology subindustry, Genor Biopharma Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genor Biopharma Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genor Biopharma Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Genor Biopharma Holdings's Days Sales Outstanding falls into.

Genor Biopharma Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Genor Biopharma Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Genor Biopharma Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	15.578	*	365 / 2
=	0					/	15.578	*	365 / 2
=	0.00

Genor Biopharma Holdings (HKSE:06998) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Genor Biopharma Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Genor Biopharma Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Genor Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genor Biopharma Holdings Ltd (HKSE:06998) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

67N0:Germany

Address

690 Bibo Road, Room 401-17, Building 6, Pudong New District, Shanghai, CHN, 201203

Website

https://www.genorbio.com

Genor Biopharma Holdings Ltd is a commercial-ready biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. The company is focused on therapeutic areas with substantial unmet medical needs in oncology, autoimmune, and other chronic diseases. Its key drug candidates include GB491 (lerociclib), a differentiated oral CDK4/6 inhibitor; GB221, a novel HER2 mAb drug candidate; geptanolimab (GB226), GB492, a STING agonist expected to exert synergistic effects in combination with GB226; GB242, an infliximab (Remicade) biosimilar; and GB223, a RANKL, and others.

Executives

Hillhouse Investment Management, Ltd.	2102 Investment manager
Hhjh Holdings Limited	2101 Beneficial owner
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hh Bio Investment Fund, L.p.	2201 Interest of corporation controlled by you
Hillhouse Capital Management, Ltd.	2102 Investment manager
Hh Bio Investment Fund L.p.	2201 Interest of corporation controlled by you
Temasek Capital (private) Limited
Aranda Investments Pte. Ltd.
Seletar Investments Pte Ltd
Walga Biotechnology Limited	2101 Beneficial owner
Shang Hai Wo Jia Sheng Wu Ji Shu You Xian Gong Si	2201 Interest of corporation controlled by you
Yun Nan Wo Sen Sheng Wu Ji Shu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited

Genor Biopharma Holdings Headlines

No Headlines